Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Innocan Pharma Corp (INNO.CN)

Innocan Pharma Corp (INNO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 347,682
  • Shares Outstanding, K 221,453
  • Annual Sales, $ 8 K
  • Annual Income, $ -9,953 K
  • 60-Month Beta N/A
  • Price/Sales 1,448.43
  • Price/Cash Flow N/A
  • Price/Book 164.82
Trade INNO.CN with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.480 +164.58%
on 08/18/21
1.650 -23.03%
on 09/16/21
+0.790 (+164.58%)
since 08/17/21
3-Month
0.400 +217.50%
on 06/24/21
1.650 -23.03%
on 09/16/21
+0.785 (+161.86%)
since 06/17/21
52-Week
0.150 +746.67%
on 10/08/20
1.650 -23.03%
on 09/16/21
+1.085 (+586.49%)
since 09/17/20

Most Recent Stories

More News
Innocan Pharma gained 350% in value this year Is it still a good time to buy? | BreezyScroll

Prospective investors should know that this is just the beginning, as according to financial analysts, InnoCan's stock surged due to the publication of its recent experimental trials. The exposure bolstered...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
TEVA : 8.99 (+0.45%)
PSTI : 3.00 (+1.35%)
BCLI : 3.53 (+1.44%)
Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

/PRNewswire/ -- Virtual Investor Conferences® and today announced that the presentations from the & 9 Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com....

INNO.CN : 1.270 (-19.11%)
CLVR : 8.61 (-0.35%)
IMCC : 2.87 (-1.71%)
INCR : 7.29 (-1.22%)
INM : 1.99 (-3.40%)
VIBEF : 0.4049 (+1.30%)
GNRSW : 0.5600 (+3.70%)
NOVC.TO : 4.33 (+0.46%)
VLNS.TO : 2.66 (+6.83%)
AUSAF : 0.1888 (-4.60%)
NVACF : 3.3900 (+0.71%)
SBUDF : 0.0279 (+8.14%)
TGIFF : 0.0667 (-0.45%)
ALEAF : 0.2800 (unch)
DLTNF : 0.3093 (-0.42%)
FFLWF : 0.6993 (-2.02%)
FLOOF : 0.0906 (+0.44%)
GNRS : 10.0900 (+0.50%)
GNRSU : 10.4600 (+0.58%)
INNPF : 1.0300 (-18.94%)
LOWLF : 0.9934 (+0.35%)
MEDIF : 0.2266 (-7.51%)
MRMD : 0.9900 (-1.98%)
NLCP : 30.0000 (unch)
VLNCF : 2.0600 (+5.10%)
VRNOF : 12.0300 (-0.41%)
CNS : 87.22 (+0.72%)
InnoCan Pharma receives strong buy recommendation: Here is why

Those who invested in InnoCan Pharma's (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) a year ago are up 273%.

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
TEVA : 8.99 (+0.45%)
PSTI : 3.00 (+1.35%)
BCLI : 3.53 (+1.44%)
Innocan Pharma's CBD-Loaded Liposome Platform Technology Demonstrates a Prolonged Release of CBD in Large Animals

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - September 3, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "" or ""), is pleased to announce that it has conducted...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

/PRNewswire/ -- Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors,...

IMCC.CN : 3.750 (+1.35%)
INNO.CN : 1.270 (-19.11%)
TGIF.CN : 0.085 (+6.25%)
VIBE.CN : 0.500 (-1.96%)
INM : 1.99 (-3.40%)
NOVC.TO : 4.33 (+0.46%)
VLNS.TO : 2.66 (+6.83%)
IMCC : 2.87 (-1.71%)
INNPF : 1.0300 (-18.94%)
MRMD : 0.9900 (-1.98%)
NVACF : 3.3900 (+0.71%)
TGIFF : 0.0667 (-0.45%)
VIBEF : 0.4049 (+1.30%)
VLNCF : 2.0600 (+5.10%)
Innocan Pharma Received Proceeds of CAD $8.2M from the Exercise of Warrants since January 1, 2021

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 27, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") reports today, that since January...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
Innocan Exercises Option to Enter into a Research and License Agreement with Ramot the Commercial company of the Tel Aviv University

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 18, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to announce that, following...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
Innocan Engages Ayurcann Inc. to Manufacture and Distribute Innocan's CBD Topicals in Canada

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 11, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan") is pleased to announce its been engaged...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
Innocan Pharma Updates its Progress in the Pre-Clinical Studies of its CBD-Loaded Liposome Platform (LPT)

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - August 3, 2021) -  Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan"), is pleased to issue an update...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)
Innocan Pharma Announces the Filing of a Patent Application for the Treatment and Prevention of Hair Loss

Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - July 28, 2021) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") filed a patent application for its...

INNO.CN : 1.270 (-19.11%)
INNPF : 1.0300 (-18.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Key Turning Points

3rd Resistance Point 1.537
2nd Resistance Point 1.463
1st Resistance Point 1.367
Last Price 1.270
1st Support Level 1.197
2nd Support Level 1.123
3rd Support Level 1.027

See More

52-Week High 1.650
Last Price 1.270
Fibonacci 61.8% 1.077
Fibonacci 50% 0.900
Fibonacci 38.2% 0.723
52-Week Low 0.150

See More

Business Summary

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. The company's operations and research and development...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar